Eversense CGM (0039)

Overview:
This is a study that will test the Eversense continuous glucose monitoring compared to a blood glucose meter in patients that are not on or ever tried a CGM.
Staus:
Enrolling
Clinical Description:
Evaluate the effectiveness of diabetes management with Eversense CGM system non-adjunctively compared to self-monitoring of blood glucose (SMBG) using a blood glucose (BG) meter in participants with either Type 1 or type 2 diabetes.
Target Age/Sex:
Over 18 years, Male and Female
Benefits:
Participants will receive at no cost: study product, study materials and study-specific procedures.
Study Length:
Aproximately 1 Year
Link:
ClinicalTrials.gov
Information Request

Information Request

To request additional information please call 208-522-6005 or email rockymountainclinicalresearch@idahomed.com or complete the form below.